| Session Introduction | |||||
|
Wed5 Oct11:00am(5 mins)
|
|
Dr Kathryn Chapman |
|
David Powell | |
|
Room: Auditorium 2
|
|||||
| Developing strategic partnerships to accelerate worldwide access to human cells | |||||
|
Wed5 Oct11:35am(30 mins)
|
|
Kam Dhaliwal |
|
David Fischer | |
|
Room: Auditorium 2
|
|||||
| Beyond Small Molecules… | |||||
|
Wed5 Oct12:35pm(15 mins)
|
|
David Madge | |||
|
Room: Auditorium 2
|
|||||
| The Drug Discovery Unit: Leading the development of new anti-infective treatments with a collaborative approach | |||||
|
Wed5 Oct02:00pm(30 mins)
|
|
Dr Beatriz Baragana | |||
|
Room: Auditorium 2
|
|||||
| Pressure over liquid – Established technology but with new value | |||||
|
Wed5 Oct02:30pm(5 mins)
|
|
Paul Kendall | |||
|
Room: Auditorium 2
|
|||||
| Building a Strong Digital Foundation to Accelerate Innovation and Drug Discovery | |||||
|
Wed5 Oct02:35pm(5 mins)
|
|
Oliver Pentinmaki | |||
|
Room: Auditorium 2
|
|||||
| Dementia Drugs through Partnership at the ALBORADA Drug Discovery Institute | |||||
|
Wed5 Oct02:40pm(30 mins)
|
|
Dr John Skidmore | |||
|
Room: Auditorium 2
|
|||||
| The benefits of working side-by-side: The Crick-GSK Biomedical LinkLabs collaboration. | |||||
|
Wed5 Oct03:45pm(30 mins)
|
|
Dr Katrin Rittinger |
|
Dr Andrew Powell | |
|
Room: Auditorium 2
|
|||||
| Advancing UK Medicines Discovery through Innovative Partnerships | |||||
|
Wed5 Oct04:15pm(30 mins)
|
|
Dr Martin Main | |||
|
Room: Auditorium 2
|
|||||
